Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
National Institutes of Health (NIH)
$10 million total funding available
Project period must not exceed 5 years
Support multi-level intervention studies addressing barriers to transition from pediatric to adult care for cancer survivors
Promote high-quality transitional care and continued engagement of survivors
Survivors of childhood and adolescent cancers
Healthcare providers
Research teams focusing on cancer survivorship
Eligible organizations include higher education institutions, nonprofits, for-profit organizations, small businesses, local and state governments, and tribal governments.
Non-domestic (non-U.S.) entities are not eligible to apply.
Organizations must be based in the U.S. or its territories.
Non-domestic components of U.S. organizations are not eligible.
Applications must focus on the evaluation of strategies or the development and testing of interventions.
Research should address barriers to care transitions specific to childhood cancer survivors.
Direct costs are limited to $499,000 per year.
No cost-sharing is required.
Application due date is October 17, 2025.
Letter of intent is recommended 30 days prior to the application due date.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
The NIH will not accept duplicate or overlapping applications under review.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
A letter of intent is strongly recommended.
Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise of the research team.
Applications will undergo scientific peer review and a second level of review by the appropriate national Advisory Council or Board.
Priority will be given to applications that address health disparities and include minority health populations.
Research teams should be multidisciplinary.
Applications must consider scalability and sustainability of interventions.
Unstructured transitions may lead to discontinuity of care and low treatment adherence.
Leveraging existing information technologies to improve care transitions.
Applications that address social determinants of health may have a competitive advantage.
Incorporation of patient feedback into intervention planning.
Collaboration between pediatric and adult healthcare providers.
Failure to address scalability and sustainability in proposed interventions.
Engage stakeholders early in the research process.
Focus on specific barriers faced by childhood cancer survivors.
Highlight unique aspects of the proposed intervention that address health disparities.